SlideShare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our User Agreement and Privacy Policy.
SlideShare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our Privacy Policy and User Agreement for details.
Successfully reported this slideshow.
Activate your 14 day free trial to unlock unlimited reading.
4.
<ul><li>Mode of transmission </li></ul><ul><li>Infection transmitted by the bite of female sandflies- genus phlebotomus (old world) or Lutzomyia (new world) </li></ul>
5.
<ul><li>Insect vectors </li></ul><ul><li>Genus- phlebotomus or lutzomyia sand flies </li></ul><ul><li>Commonly found in house-hold rubbish, bark of old trees,cracks in walls </li></ul><ul><li>Usually feed at night while the host asleep </li></ul><ul><li>30 of 500 spp.. Of phlebotomine sand flies can transmit ds. </li></ul><ul><li>Ex P.argentipes (Indian sub- continent) </li></ul><ul><li>P.oriantalis (Africa, mediterranean basin) </li></ul><ul><li>P.chinensis&alexandri (china) </li></ul><ul><li>. </li></ul>
7.
Life cycle <ul><li>Reservoir hosts – wild and domestic animals such as fox,jackal,rodents and wolves </li></ul><ul><li>Domestic dogs plays imp role in harbouring and transmitting disease to humans </li></ul><ul><li>Man – incidental host </li></ul><ul><li>Source of infection – asymptomatic carriers and PKDL patients </li></ul>
8.
<ul><li>Parasite occures in two stages </li></ul><ul><li>Amastigote- Aflagellar stage (seen in the R.E.vertebrate host) </li></ul><ul><li>Promastigote-Flagellar stage( seen in gut of sandfly,Artificial culture) </li></ul>
9.
<ul><li>1. AMASTIGOTE FORM </li></ul><ul><li>2.PROMASTIGOTE FORM </li></ul>
12.
<ul><li>Visceral leishmaniasis </li></ul><ul><li>Also called as kala-azar(black-fever) </li></ul><ul><li>>90% of vl occurs in Bangladesh ,India (Bihar),Nepal, Sudan and brazil. </li></ul><ul><li>Caused by especially L. donovani complex transmitted by bite of female sand fly (P.argentipes) </li></ul><ul><li>Ds.can also be transmitted congenitally and parenterally. </li></ul>
13.
<ul><li>Clinical features </li></ul>Subclinical, but can be occures in acute, subacute, or chronic form I.P. weeks to months but can be, as long as years also Symptoms- 1.fever-highgrade,2peaks in 24hrs,ass.with chills and rigors 2.drenching sweats (malaria) 3.weight loss, poor appetite, anorexia 4.cough,burning feet, insomnia 5.abdominal pain, joint pain, epistaxis, diarrhoea 6.neurological affects are rare
14.
signs <ul><li>Splenomegaly (soft, non tender),can be massive </li></ul><ul><li>Hepatomegaly </li></ul><ul><li>Peripheral lymphadenopathy </li></ul><ul><li>Dark skin </li></ul><ul><li>anemia </li></ul>
16.
Post kala-azar dermal leishmaniasis (PKDL) <ul><li>Usually follows recovery from kala azar </li></ul><ul><li>Begins with small measles like skin leisons- </li></ul><ul><li>hypopigmented macules,papuples, nodules </li></ul><ul><li>Typically more prominent on face,eventuall spread to other areas. </li></ul><ul><li>Can dev.during therapy,few moths,years later (india) </li></ul><ul><li>Self limiting (resolving in six months) </li></ul>
17.
Cutaneous leishmaniasis <ul><li>It’s a most common form of leishmaniasis </li></ul><ul><li>>90% cases occures in afghanistan, algeria, iraq, iran soudi arabia </li></ul><ul><li>It is transmitted by P.sergenti,P.papatasi </li></ul><ul><li>Papule, nodules, ulcerative lesions </li></ul><ul><li>Resembles warts, acne, psoriasis </li></ul><ul><li>Not painful </li></ul><ul><li>Extremities and face </li></ul><ul><li>Heal over months to years-scars-burns </li></ul><ul><li>Diffuse cutaneous L. – severe form </li></ul>
18.
Muco cutaneous leishmaniasis (Espundia) <ul><li>Less common </li></ul><ul><li>Most commonly caused by viannia sub gen. (V. brazilliensis) </li></ul><ul><li>Involves nose ,mouth, larynx </li></ul><ul><li>Unusual nasal symptoms- epistaxis, edema, erythema of nasal mucosa </li></ul><ul><li>Nodules like CL, Inside nose- perforation nasal septum ,enlarged lips&nose ,larynx-voice change </li></ul>
21.
<ul><li>1. VISCERAL LEISHMANIASIS </li></ul><ul><li>1.clinical features but not sufficient </li></ul><ul><li>2.microscopic exam (amastigote form) </li></ul><ul><li>3.blood cultures </li></ul><ul><li>4.serological tests-ELISA </li></ul><ul><li>5.strip test-using k39 (recombinent </li></ul><ul><li>protein) </li></ul>
22.
<ul><li>2.CUTANEOUS & MUCOCUTANEOUS LEISHMANIASIS </li></ul><ul><li>staining method- Giemsa-stain(smears of dermal scrapings), </li></ul><ul><li>in vitro cultures (using aspirates from lymph nodes & skin lesions) </li></ul><ul><li>biopsy specimens for culture & PCR methods </li></ul><ul><li>serological tests-insensitive (AB titers low) </li></ul>
24.
<ul><li>LEISHMANIN TEST </li></ul><ul><li>*+ Ve in 6-8 wks after recovery </li></ul><ul><li>* Delayed hyper sensitivity </li></ul><ul><li>*+ Ve in african kala azar, not in Indian kala azar </li></ul><ul><li>*- Ve in PKDL,untreated cases </li></ul>
25.
TREATMENT <ul><li>1. VISCERAL LEISHMANIASIS </li></ul><ul><li>* 1.Pentavalent antimonial compounds- </li></ul><ul><li>Inj.sodium stibogluconate (pentostam) </li></ul><ul><li>IVM 20mgg body wt. for 28days </li></ul><ul><li>*Inj.pentamidine IM 2-4mgg body </li></ul><ul><li>wt. for 10-15days </li></ul><ul><li>* Inj.Amphotericine B( preffered in India) IV </li></ul><ul><li>2-5mgg qd ( total 2-3gm) given </li></ul>
26.
<ul><li>*Inj. paromomycine IVM 15-20mgg qd for 21days </li></ul><ul><li>*Miltefosine orally 50-100mgay for 28days </li></ul><ul><li>*Allopurinol ORALV 20mgg for 3days </li></ul>
27.
<ul><li>2.CUTANEOUS LEISHMANIASIS </li></ul><ul><li>* self healing (within 6 months) </li></ul><ul><li>* treatment depends on spp.and country </li></ul><ul><li>of acquisition </li></ul><ul><li>* Pentavalent antimonial compounds IVM </li></ul><ul><li>20mgg qd for 10-20days </li></ul><ul><li>* Pentamidine IVM 3mggfor 4 doses or 2mgg for 7 doses </li></ul>
28.
<ul><li>* Amphotericine B(deoxycholate) IV 0.5-1mgg qd (total 20mgg) for 8wks </li></ul><ul><li>* Oral-Fuconazole 200mg qd or bd for 6wks </li></ul><ul><li>Ketoconazole 600mgay 28 days </li></ul><ul><li>Itraconazole 200mg bd for 28 days </li></ul><ul><li>Dapsone 100mg bd for 6 wks </li></ul>
29.
<ul><li>Local OR Topical- drugtherapy </li></ul><ul><li>Paromomycine ointment, methylbenzethonium chloride </li></ul><ul><li>Intra-lesional inj. of megutamineantimoniate </li></ul><ul><li>Non drug therapy-local heat therapy, cryo </li></ul>
30.
<ul><li>3.MUCUCUTANEOUS LEISHMANIASIS </li></ul><ul><li>* Pentavalent antimony IVM 20mgg qd for 28 days </li></ul><ul><li>* Amphotericine B(deoxycholate) IV 1mgg qd (total 20-40mg) </li></ul><ul><li>* Pentamidine IVM 2-4mgg thricekly for >15 doses </li></ul>
31.
prognosis <ul><li>* CL rarely fatal-disfiguring scars </li></ul><ul><li>* VL-untreated&severe cases almost fatal </li></ul><ul><li>* Death –organ failure,wasting synd. </li></ul><ul><li>* Pt.with HIV- Treat HIV, along the leishmaniasis avoid relapses. </li></ul>
32.
Prevention and control <ul><li>By avoiding the bite of female sandflies </li></ul><ul><li>Insect repellents-DEET </li></ul><ul><li>Bed-nets,cloths,and screens impregnated with permethrin </li></ul><ul><li>Treat human cases (L. donovani inf. in India) </li></ul>